Integra Lifesciences Holdings Corp Company Profile (NASDAQ:IART)

About Integra Lifesciences Holdings Corp (NASDAQ:IART)

Integra Lifesciences Holdings Corp logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

Industry, Sector and Symbol:
  • Sector:
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:IART
  • CUSIP: 45798520
  • Web: www.integralife.com
Capitalization:
  • Market Cap: $3.71 billion
  • Outstanding Shares: 75,620,000
Average Prices:
  • 50 Day Moving Avg: $45.01
  • 200 Day Moving Avg: $54.22
  • 52 Week Range: $36.58 - $50.05
P/E:
  • Trailing P/E Ratio: 58.39
  • Foreward P/E Ratio: 22.09
  • P/E Growth: 2.22
Sales & Book Value:
  • Annual Revenue: $1.01 billion
  • Price / Sales: 3.67
  • Book Value: $11.33 per share
  • Price / Book: 4.33
Profitability:
  • EBIDTA: $235.27 million
  • Net Margins: 6.09%
  • Return on Equity: 16.11%
  • Return on Assets: 7.00%
Debt:
  • Debt-to-Equity Ratio: 0.80%
  • Current Ratio: 3.17%
  • Quick Ratio: 1.81%
Misc:
  • Average Volume: 572,258 shs.
  • Beta: 0.8
  • Short Ratio: 13.19
 

Frequently Asked Questions for Integra Lifesciences Holdings Corp (NASDAQ:IART)

What is Integra Lifesciences Holdings Corp's stock symbol?

Integra Lifesciences Holdings Corp trades on the NASDAQ under the ticker symbol "IART."

When did Integra Lifesciences Holdings Corp's stock split? How did Integra Lifesciences Holdings Corp's stock split work?

Integra Lifesciences Holdings Corp shares split on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly created shares were issued to shareholders after the market closes on Wednesday, December 21st 2016. An investor that had 100 shares of Integra Lifesciences Holdings Corp stock prior to the split would have 200 shares after the split.

How were Integra Lifesciences Holdings Corp's earnings last quarter?

Integra Lifesciences Holdings Corp (NASDAQ:IART) released its quarterly earnings results on Wednesday, April, 26th. The company reported $0.39 EPS for the quarter, missing the Zacks' consensus estimate of $0.40 by $0.01. The firm had revenue of $258.60 million for the quarter, compared to analysts' expectations of $254.19 million. Integra Lifesciences Holdings Corp had a net margin of 6.09% and a return on equity of 16.11%. Integra Lifesciences Holdings Corp's revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.38 EPS. View Integra Lifesciences Holdings Corp's Earnings History.

What guidance has Integra Lifesciences Holdings Corp issued on next quarter's earnings?

Integra Lifesciences Holdings Corp updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided earnings per share guidance of $1.88-1.94 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.91. The company issued revenue guidance of $1.12-1.14 billion, compared to the consensus revenue estimate of $1.13 billion.

Where is Integra Lifesciences Holdings Corp's stock going? Where will Integra Lifesciences Holdings Corp's stock price be in 2017?

10 brokers have issued 1-year target prices for Integra Lifesciences Holdings Corp's stock. Their predictions range from $42.00 to $54.00. On average, they anticipate Integra Lifesciences Holdings Corp's stock price to reach $48.94 in the next year. View Analyst Ratings for Integra Lifesciences Holdings Corp.

Who are some of Integra Lifesciences Holdings Corp's key competitors?

Who are Integra Lifesciences Holdings Corp's key executives?

Integra Lifesciences Holdings Corp's management team includes the folowing people:

  • Stuart M. Essig Ph.D., Independent Chairman of the Board
  • Peter J. Arduini, President, Chief Executive Officer, Director
  • Glenn G. Coleman, Chief Financial Officer, Principal Accounting Officer, Corporate Vice President
  • Lisa Evoli, Corporate Vice President, Chief Human Resources Officer
  • Kenneth Burhop Ph.D., Chief Scientific Officer, Corporate Vice President
  • John Mooradian, Corporate Vice President - Global Operations and Supply Chain
  • Richard D. Gorelick, Corporate Vice President, General Counsel, Administration, Secretary
  • Robert T. Davis Jr., Corporate Vice President, President — Specialty Surgical Solutions
  • Judith E. O'Grady R.N., Corporate Vice President - Global Regulatory Affairs
  • Daniel L. Reuvers, Corporate Vice President, President - Specialty Surgical Solutions

Who owns Integra Lifesciences Holdings Corp stock?

Integra Lifesciences Holdings Corp's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (10.07%), BlackRock Inc. (9.86%), Vanguard Group Inc. (7.48%), Champlain Investment Partners LLC (5.87%), Wells Fargo & Company MN (3.30%) and Janus Capital Management LLC (2.79%). Company insiders that own Integra Lifesciences Holdings Corp stock include Christian S Schade, Daniel L Reuvers, Glenn Coleman, James M Sullivan, Joseph Vinhais, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Institutional Ownership Trends for Integra Lifesciences Holdings Corp.

Who sold Integra Lifesciences Holdings Corp stock? Who is selling Integra Lifesciences Holdings Corp stock?

Integra Lifesciences Holdings Corp's stock was sold by a variety of institutional investors in the last quarter, including Mesirow Financial Investment Management Equity Management and Capstone Asset Management Co.. Company insiders that have sold Integra Lifesciences Holdings Corp stock in the last year include Glenn Coleman, James M Sullivan, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig. View Insider Buying and Selling for Integra Lifesciences Holdings Corp.

Who bought Integra Lifesciences Holdings Corp stock? Who is buying Integra Lifesciences Holdings Corp stock?

Integra Lifesciences Holdings Corp's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., Champlain Investment Partners LLC, FMR LLC, Janus Capital Management LLC, Dimensional Fund Advisors LP, State Street Corp and Eagle Asset Management Inc.. View Insider Buying and Selling for Integra Lifesciences Holdings Corp.

How do I buy Integra Lifesciences Holdings Corp stock?

Shares of Integra Lifesciences Holdings Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Integra Lifesciences Holdings Corp's stock price today?

One share of Integra Lifesciences Holdings Corp stock can currently be purchased for approximately $49.05.


MarketBeat Community Rating for Integra Lifesciences Holdings Corp (NASDAQ IART)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  210 (Vote Outperform)
Underperform Votes:  216 (Vote Underperform)
Total Votes:  426
MarketBeat's community ratings are surveys of what our community members think about Integra Lifesciences Holdings Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Integra Lifesciences Holdings Corp (NASDAQ:IART) (?)
Ratings Breakdown: 3 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $48.94 (0.23% downside)

Analysts' Ratings History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/23/2017ValuEngineDowngradeBuy -> HoldLowView Rating Details
5/15/2017Oppenheimer Holdings Inc.Set Price TargetBuy$54.00LowView Rating Details
5/2/2017Royal Bank of CanadaReiterated RatingSector Perform -> Sector Perform$46.00 -> $48.00LowView Rating Details
4/28/2017Jefferies Group LLCBoost Price TargetBuy$50.00 -> $52.00LowView Rating Details
3/22/2017Piper Jaffray CompaniesReiterated RatingOverweight$47.00LowView Rating Details
1/13/2017Barclays PLCReiterated RatingEqual Weight$84.00 -> $42.00N/AView Rating Details
1/6/2017JMP SecuritiesUpgradeMarket Perform -> Outperform$50.00N/AView Rating Details
10/28/2016Lake Street CapitalUpgradeHold -> Buy$46.00N/AView Rating Details
9/23/2016ArgusBoost Price TargetBuy$45.00 -> $52.50N/AView Rating Details
7/13/2016JPMorgan Chase & Co.Initiated CoverageOverweightN/AView Rating Details
11/12/2015Citigroup IncInitiated CoverageBuy$37.50N/AView Rating Details
9/21/2015Bank of America CorpUpgradeNeutral -> Buy$36.00 -> $39.50N/AView Rating Details
7/29/2015Raymond James Financial, Inc.UpgradeMarket Perform -> OutperformN/AView Rating Details
(Data available from 5/30/2015 forward)

Earnings

Earnings History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Earnings by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Earnings History by Quarter for Integra Lifesciences Holdings Corp (NASDAQ IART)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017Q1 17$0.40$0.39$254.19 million$258.60 millionViewN/AView Earnings Details
2/23/2017Q4 2016$0.52$0.52$257.27 million$255.70 millionViewN/AView Earnings Details
10/27/2016Q3$0.89$0.93$249.30 million$250.30 millionViewListenView Earnings Details
7/28/2016Q216$0.76$0.79$243.17 million$249.30 millionViewListenView Earnings Details
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details
7/30/2015Q215$0.73$0.79$239.91 million$244.10 millionViewListenView Earnings Details
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details
8/5/2014Q214$0.63$0.68$229.32 million$231.40 millionViewN/AView Earnings Details
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details
10/24/2012$0.77$0.85ViewN/AView Earnings Details
7/26/2012$0.69$0.74ViewN/AView Earnings Details
4/25/2012$0.60$0.71ViewN/AView Earnings Details
2/23/2012$0.55$0.72ViewN/AView Earnings Details
10/31/2011$0.77$0.77ViewN/AView Earnings Details
7/28/2011$0.61$0.70ViewN/AView Earnings Details
4/28/2011$0.66$0.66ViewN/AView Earnings Details
2/24/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Integra Lifesciences Holdings Corp (NASDAQ:IART)
2017 EPS Consensus Estimate: $1.92
2018 EPS Consensus Estimate: $2.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.38$0.48$0.42
Q2 20174$0.43$0.47$0.45
Q3 20174$0.42$0.52$0.49
Q4 20174$0.54$0.60$0.57
Q1 20182$0.46$0.51$0.49
Q2 20182$0.51$0.55$0.53
Q3 20182$0.57$0.57$0.57
Q4 20182$0.65$0.70$0.68
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Insider Ownership Percentage: 21.40%
Institutional Ownership Percentage: 44.37%
Insider Trades by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Institutional Ownership by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Insider Trades by Quarter for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Stuart EssigDirectorSell135,000$49.90$6,736,500.00View SEC Filing  
5/23/2017Stuart EssigDirectorSell140,000$48.01$6,721,400.00View SEC Filing  
5/4/2017Glenn ColemanVPSell13,865$45.91$636,542.15View SEC Filing  
5/4/2017James M SullivanDirectorSell15,658$45.89$718,545.62View SEC Filing  
11/8/2016Peter J ArduiniCEOSell24,009$79.51$1,908,955.59View SEC Filing  
8/23/2016Raymond G MurphyDirectorSell2,600$86.64$225,264.00View SEC Filing  
8/9/2016Peter J ArduiniCEOSell24,009$84.52$2,029,240.68View SEC Filing  
8/4/2016Raymond G MurphyDirectorSell2,610$84.83$221,406.30View SEC Filing  
8/1/2016Richard D GorelickVPSell4,000$84.60$338,400.00View SEC Filing  
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Latest Headlines for Integra Lifesciences Holdings Corp (NASDAQ:IART)
Source:
DateHeadline
finance.yahoo.com logoIntegra LifeSciences (IART) Up 8.5% Since Earnings Report: Can It Continue?
finance.yahoo.com - May 29 at 9:43 AM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Director Stuart Essig Sells 135,000 Shares
www.americanbankingnews.com - May 26 at 7:26 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 26 at 2:53 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Director Sells $6,721,400.00 in Stock
www.americanbankingnews.com - May 24 at 7:21 PM
nasdaq.com logoIntegra LifeSciences to Offer aap's LOQTEQ System in the US
www.nasdaq.com - May 24 at 5:40 PM
finance.yahoo.com logoIntegra LifeSciences to Present at Healthcare Conferences in June 2017
finance.yahoo.com - May 24 at 5:40 PM
americanbankingnews.com logoValuEngine Lowers Integra Lifesciences Holdings Corp (IART) to Hold
www.americanbankingnews.com - May 23 at 5:04 PM
reuters.com logoBRIEF-Integra Lifesciences Holdings Corp signs an agreement with AAP Implantate AG
www.reuters.com - May 23 at 11:24 AM
finance.yahoo.com logoIntegra LifeSciences Announces Agreement with aap to Distribute LOQTEQ® Distal Radius System
finance.yahoo.com - May 23 at 11:24 AM
finance.yahoo.com logoIntegra LifeSciences Announces the European Launch of Integra® Dermal Regeneration Template Single Layer "Thin"
finance.yahoo.com - May 17 at 10:04 AM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Given a $54.00 Price Target by Oppenheimer Holdings Inc. Analysts
www.americanbankingnews.com - May 15 at 2:34 PM
finance.yahoo.com logoIntegra LifeSciences launches SurgiMend® MP Collagen Matrix for Hernia Repair
finance.yahoo.com - May 12 at 6:30 PM
finance.yahoo.com logoETFs with exposure to Integra LifeSciences Holdings Corp. : May 11, 2017
finance.yahoo.com - May 11 at 6:23 PM
americanbankingnews.com logo Analysts Anticipate Integra Lifesciences Holdings Corp (IART) Will Post Quarterly Sales of $282.89 Million
www.americanbankingnews.com - May 6 at 8:47 AM
americanbankingnews.com logoInsider Selling: Integra Lifesciences Holdings Corp (IART) Director Sells 15,658 Shares of Stock
www.americanbankingnews.com - May 5 at 8:11 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) VP Sells $636,542.15 in Stock
www.americanbankingnews.com - May 5 at 8:11 PM
americanbankingnews.com logo Analysts Anticipate Integra Lifesciences Holdings Corp (IART) to Post $0.44 Earnings Per Share
www.americanbankingnews.com - May 4 at 1:24 PM
finance.yahoo.com logoIntegra LifeSciences to Present at Healthcare Conferences in May 2017
finance.yahoo.com - May 3 at 5:26 PM
americanbankingnews.com logoPositive Media Coverage Very Likely to Impact Integra Lifesciences Holdings Corp (IART) Stock Price
www.americanbankingnews.com - May 2 at 6:10 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Given New $48.00 Price Target at Royal Bank of Canada
www.americanbankingnews.com - May 2 at 7:54 AM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 1 at 6:38 PM
americanbankingnews.com logoJefferies Group Comments on Integra Lifesciences Holdings Corp's Q4 2017 Earnings (IART)
www.americanbankingnews.com - May 1 at 11:34 AM
americanbankingnews.com logoQ2 2017 EPS Estimates for Integra Lifesciences Holdings Corp Raised by Northcoast Research (IART)
www.americanbankingnews.com - May 1 at 8:11 AM
americanbankingnews.com logoFavorable Press Coverage Likely to Impact Integra Lifesciences Holdings Corp (IART) Stock Price
www.americanbankingnews.com - April 29 at 8:50 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Given Buy Rating at Jefferies Group LLC
www.americanbankingnews.com - April 29 at 1:05 AM
finance.yahoo.com logoIntegra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q1, 2017 By the Numbers : April 28, 2017
finance.yahoo.com - April 28 at 6:46 PM
americanbankingnews.com logoJefferies Group Analysts Raise Earnings Estimates for Integra Lifesciences Holdings Corp (IART)
www.americanbankingnews.com - April 28 at 1:25 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Forecasted to Post Q2 2017 Earnings of $0.44 Per Share
www.americanbankingnews.com - April 28 at 7:54 AM
finance.yahoo.com logoEdited Transcript of IART earnings conference call or presentation 26-Apr-17 12:30pm GMT
finance.yahoo.com - April 27 at 6:24 PM
zacks.com logoIntegra LifeSciences (IART) Misses Q1 Earnings, Retains View
www.zacks.com - April 27 at 8:33 AM
rttnews.com logoIntegra Lifesciences Holdings Corp Announces 9% Advance In Q1 Profit
www.rttnews.com - April 26 at 7:30 PM
seekingalpha.com logoIntegra LifeSciences Holdings Corporation 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - April 26 at 7:30 PM
finance.yahoo.com logoIntegra LifeSciences Reports First Quarter 2017 Financial Results
finance.yahoo.com - April 26 at 7:30 PM
finance.yahoo.com logoIntegra misses 1Q profit forecasts
finance.yahoo.com - April 26 at 7:30 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Receives Coverage Optimism Score of 0.06
www.americanbankingnews.com - April 26 at 12:53 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Issues Earnings Results
www.americanbankingnews.com - April 26 at 12:18 PM
finance.yahoo.com logoIntegra LifeSciences Holdings Corp. – Value Analysis (NASDAQ:IART) : April 24, 2017
finance.yahoo.com - April 24 at 5:29 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Getting Favorable Press Coverage, Analysis Finds
www.americanbankingnews.com - April 23 at 8:45 AM
finance.yahoo.com logoIntegra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : April 21, 2017
finance.yahoo.com - April 21 at 10:50 AM
americanbankingnews.com logoSomewhat Positive Press Coverage Extremely Likely to Affect Integra Lifesciences Holdings Corp (IART) Stock Price
www.americanbankingnews.com - April 18 at 12:15 AM
finance.yahoo.com logoIntegra LifeSciences' Stock Split: Why It Accomplished Nothing
finance.yahoo.com - April 15 at 5:03 PM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Expected to Post Quarterly Sales of $254.75 Million
www.americanbankingnews.com - April 15 at 8:58 AM
americanbankingnews.com logo Brokerages Expect Integra Lifesciences Holdings Corp (IART) Will Announce Earnings of $0.40 Per Share
www.americanbankingnews.com - April 13 at 1:06 PM
globenewswire.com logoIntegra LifeSciences to Host Its First Quarter 2017 Earnings Results ...
globenewswire.com - April 12 at 5:57 PM
finance.yahoo.com logoIntegra LifeSciences to Host Its First Quarter 2017 Earnings Results Conference Call on April 26, 2017
finance.yahoo.com - April 12 at 5:57 PM
finance.yahoo.com logoIntegra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan
finance.yahoo.com - April 7 at 10:20 AM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp (IART) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 4 at 2:07 PM
finance.yahoo.com logoWhy One Analyst Sees Almost 40% Upside in Integra LifeSciences
finance.yahoo.com - April 3 at 3:19 PM
reuters.com logoBRIEF-Integra Lifesciences announces commercial expansion of Cadence Total Ankle System
www.reuters.com - March 29 at 10:42 AM
americanbankingnews.com logoIntegra Lifesciences Holdings Corp Forecasted to Earn Q1 2017 Earnings of $0.48 Per Share (IART)
www.americanbankingnews.com - March 29 at 10:29 AM

Social

Chart

Integra Lifesciences Holdings Corp (IART) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff